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Abstract The yield of fiberoptic bronchoscopy (FB) in the diagnosis of pulmonarymetastases has not been conveni-
ently analyzed.Withthe advancesinthe surgeryofpulmonarymetastases, there is a needto evaluatethe diagnostic yield
and the usefulness of FB to exclude other diseaseswith similar radiological patterns.To determine the value of FB in the
diagnosis ofpulmonarymetastaseswehaveretrospectivelyanalyzedourexperiencein113 patientswithprovenpulmon-
arymetastases. An endobronchial lesionwas identified in 57/113 (50.4%).Themost frequenttumorswith endobronchial
lesionswere thyroid (100%), head^neck (67%) and breast carcinomas (59%).The highest diagnostic yieldwas obtained
combining techniques of brushing, washing and biopsy (72.6%); in cases with endobronchial lesions (84.2%) and with
certainhistologicaltypes (head^neck100%; breast 90.9% andcolon 84.6%).Themostfrequentradiological findingswere
single ormultiplenodules (77.9%).Atelectasiswere associatedwith endobronchiallesions.Inconclusion, bronchoscopyis
a valuable diagnostic procedure in selectedpatientswithmetastatic lungdisease.r2002 Elsevier Science Ltd.Allrights reserved
Available online athttp://www.sciencedirect.com
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Combining techniques of brushing, washing and biopsy
by ¢beroptic bronchoscopy (FB), the diagnosis of
bronchogenic carcinoma can be con¢rmed in 79^85%
of patients (1^13).However, in cases ofmetastatic cancer
to the lungs, the diagnostic yield of FB has been very low
and very di¡erent among groups who have reported
their experience (30% positive cytology and 50% trans-
bronchial biopsy (2); 54% combining techniques of brush-
ing, washing and biopsy (4,5).
With the advances in surgery of pulmonary metas-
tases (6,7), it is necessary to evaluate the diagnostic yield
of FB and its usefulness to exclude otherdiseases (oppor-
tunistic pulmonary infection, pulmonary hemorrhage or
drug-induced lung disease) whichmay simulate radiologi-
cal patterns of metastases in patients with controlled or
uncontrolled extrapulmonary neoplasms.
We retrospectively reviewed113 patients with proven
pulmonary metastases in order to assess the diagnostic
yield of FB in patients suspected of having metastatic
lung disease.We attempted to identify the endoscopic,
roentgenographic andpathologic features that areuseful
in predicting a positive result.Received 8 May 2002, accepted in revised form 5 July 2002.
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Madrid, Spain. E-mail: djc_69_98yahoo.comMATERIALANDMETHODS
We retrospectively reviewed 153 patients with proven
pulmonary metastases. They had been referred to the
Bronchoscopy Unit between 1993 and 2000 because of
an abnormal chest roentgenogram and had either a his-
tory of prior extrapulmonarymalignancy or unexplained
pulmonary disease without prior history of malignant
disease but where further work-up determined the lung
disease to be metastatic. The Bronchoscopy Unit is lo-
cated at Ramo¤ n y Cajal Hospital, a referred tertiary
medical center in Spain.
Selective inclusion criteria were: (a) known or un-
known primary tumor with cytopathologic proven me-
tastases; (b) knownprimary tumor with abnormal X-ray
and without cytopathologic proven metastases and (c)
unknown primary tumor with suspected metastases in
chest X-ray andproven extrapulmonarymetastases. Se-
lective exclusion criteriawere: (a) bronchogenic carcino-
ma; (b) hematologic malignancy; (c) uncontrolled
esophageal or larynx carcinoma. All of the cases were
cytopathologic proven (sputum, washing, brushing,
biopsy, surgical or postmortem examination).
The Olympus BF-T30 or Olympus BF-P20 broncho¢-
berscopeswereutilized. Individual andcombining techni-
ques of washing and brushing were performed in all
patients, bronchial biopsy in patients with visible
endobronchial lesions and transbronchial biopsy under
28 RESPIRATORYMEDICINE£uoroscopic guidance in patients without visible endo-
scopic lesions by decision of the bronchoscopist.
Information obtained from each record included (1)
visible or notvisible endoscopic lesion; (2) site of primary
malignancy and pathologic type; (3) radiological ¢ndings
and (4) surgical indication.
The data underwent statistical analysis using chi-
square and Fisher exact testwithYates correction. Statis-
tical signi¢cant di¡erencewas consideredwith Po0.05.
RESULTS
One hundred and thirteen ¢beroptic bronchoscopic pro-
cedures were analyzed in 113 patients with proven pul-
monary metastases. Forty cases were excluded on
applying selective criteria. Finally, there were 53 men
(46.9%) and 60 women (53.1%) with a mean age of
46.5711 years. All cases were cytopathologic proven
(washing, 44.2%; brushing, 50.4%; endobronchial biopsy,
61.1%; surgical,10.6%; or postmortem examination,16.8%).
In11patients no primary cancer could be detected.
Examination with a £exible bronchoscope was diag-
nostic in 82 cases (72.6%). The specimens obtained and
the yield of each are listed in Table 1. In the group as a
whole, therewas no di¡erence in the diagnostic yield be-
tween washing, brushing or biopsy, but combining tech-TABLE 1. Broncho¢beroscopic yield inpulmonarymetastases a
Visible (%) Not
Number 57 (50.4) 5
Washing (W) 34 (59.6) 1
Brushing (BR) 41 (71.9) 1
Biopsy (BP) 35 (61.4) 3
W^BR 44 (77.2) 2
W^BR^BP 48 (84.2) 3
aTransbronchial biopsyperformedin ¢ve cases (positive 3/5).
bBrushing vs. washing
cBiopsy vs. brushing
dWashingand brushing vs. washing.
4Washing, brushingandbiopsy vs. washingandbrushing.
TABLE 2. Broncho¢beroscopic yield according to radiographic
Single noduleN (%) Multiple nodul
Number (%) 43 (38.0) 45 (39.8
Washing (W) 19 (44.2) 16 (35.5
Brushing (BR) 21 (48.8) 18 (40.0
Biopsy (BP) 26 (60.5) 23 (51.1)
W^BR 25 (58.1) 23 (51.1)
W^BR^BP 31 (72.1) 29 (64.4
Endoscopic lesion 26 (60.5) 13 (28.9niques performed signi¢cantly better than individual
ones (Table1).
An endobronchial lesion was visible in 57 patients
(50.4%) and a positive result was obtained by either for-
ceps biopsy, washing and/or brushing in 48 patients
(84.2%).When an endobronchial lesionwas not visible, a
positive diagnosis was recorded in 34 of the 56 (60.7%).
The diagnostic yieldwas signi¢cantly better for all speci-
mens except for biopsy in cases of visible lesions in con-
trast with thosewithout visible ones.
The roentgenographic pattern of atelectasis favored a
positive result while the identi¢cation of multiples no-
dules was associatedwith the fewest diagnoses of malig-
nancies (Table 2). There was a signi¢cant correlation
between the presence of an endobronchial lesion and a
pattern of atelectasis.
Table 3 shows the diagnostic yield of di¡erent speci-
mens according to the site of the primary neoplasm.
The highest diagnostic yield was obtained in cases of
head^neck andbreast tumors and the lowest one in sar-
comas and kidney neoplasms.
DISCUSSION
The lung is often involved when extrapulmonary malig-
nancies metastasize, and FB is frequently performed asccording tomethod and endobronchialvisibility
visible (%) Total (%) P
6 (49.6) 113 (100)
6 (28.6) 50 (44.2)
6 (28.6) 57 (50.4) NSb
4 (60.7)a 69 (61.1)a NSc
3 (41.1) 67 (59.3) 0.03d
4 (60.7)a 82 (72.6)a 0.04e
¢ndings
esN (%) AtelectasisN (%) Di¡use in¢ltrateN (%)
) 17 (15.0) 8 (7.1)
) 10 (58.8) 5 (62.5)
) 12 (70.6) 6 (75.0)
15 (88.2) 5 (62.5)
13 (76.5) 6 (75.0)
) 16 (94.1) 6 (75.0)
) 15 (88.2) 3 (37.5)
TABLE 3. Broncho¢beroscopic yield according to primary tumor
Primary tumor Number Visible (%) Washing (W) (%) Brushing (BR) (%) Biopsy (BP) (%) W^BR (%) W^BR^BP (%)
Head^neck 6 66.7 66.7 66.7 66.7 83.3 100.0
Breast 22 59.1 50.0 77.3 36.4 90.9 90.9
Colorectal 13 46.1 38.5 53.8 69.2 53.8 84.6
Thyroid 7 100.0 28.6 57.1 85.7 57.1 85.7
Genitourinary 12 50.0 25.0 25.0 66.7 33.3 66.7
Sarcoma 14 21.4 50.0 42.9 64.3 50.0 64.3
Kidney 14 42.9 21.4 28.6 42.9 35.7 57.1
YIELDOFBRONCHOSCOPYANDPULMONARYMETASTASES 29part of the patients’ subsequent evaluation. We con-
ducted this study to investigatewhichmalignanciesmost
commonlymetastasize endobronchially and what radio-
graphic clues suggest abnormal endobronchial anatomy
so that a reasonable decision can be made as to when
FBwill be a potentially high-yield procedure.
Endobronchial biopsy was positive in 48 of 57 patients
(84.2%) with endobronchial lesions and in 60.7% of pa-
tients with normal FB.We do not agree with Argyros et
al. (8) that FB must not be performed in patients with a
low pretest probability of endobronchial abnormality.
Our study supports the bene¢t of combining forceps
biopsy with brush cytology when bronchoscopy is done
in the patient withmetastatic disease.
We agreewith Poe et al. (9) and Braman et al. (10) that
the roentgenographic ¢nding of atelectasis is frequently
associated with endobronchial metastases and a higher
yield of tissue diagnosis.
Breast carcinoma accounts for a large number of pa-
tients in our series.Our ¢ndings agreewithpriorreports
(4,8,9,11,12).We attribute this to theprevalence of this dis-
ease in the general population.We found FB most fre-
quently diagnostic in patients with head and neck
carcinoma followed by breast carcinoma. Perhaps, this is
because the high frequency of endobronchial lesions as-
sociated with this cancer in the population studied. Car-
cinoma of the kidney, described as frequently
metastazing to large airways simulating bronchogenic
carcinoma (13,14), was not as frequently seen at broncho-
scopy in our patient population.
In conclusion, our study indicates that FB is safe and of
great value in the diagnosis of metastatic cancer to the
lungs, and is particulary helpful in cases of endobronchial
visible lesions. Endobronchial metastases are relatively
common and evenmore in the presence of atelectasis in
the chest X-ray. Both forceps biopsy and brush cytologyspecimens should be obtained in order to achieve the
maximum diagnostic yield. Breast and head^neck carci-
noma were the most common primary sites of malig-
nancy.
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